VanEck Pharmaceutical ETF
Limited financial coverage for PPH.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
- IPO
- 2000
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on PPH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.02B
- Div Yield
- 1.82%
- 52W High
- $124.17
- 52W Low
- $97.52
- 50D MA
- $114.25
- 200D MA
- $108.87
- Beta
- 0.43
- RSI (14)
- 43
- Avg Volume
- 328.64K
No earnings-call transcripts are available for PPH yet.
- Free Float
- —
- Shares Outstanding
- 8.79M
- Float Shares
- —
of shares held by institutions
156 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Morgan Stanley | 1.20M | ▲ 167.28K |
| Goldman Sachs Group Inc | 1.18M | ▲ 192.86K |
| Healthcare Of Ontario Pension Plan Trust Fund | 402.00K | 0 |
| J.Safra Asset Management Corp | 328.31K | ▲ 8.68K |
| Ubs Group AG | 315.89K | ▼ 201.86K |
| Susquehanna International Group, Llp | 281.66K | ▲ 197.45K |
| Avalon Trust Co | 254.16K | ▼ 9.68K |
| Bnp Paribas Financial Markets | 152.26K | ▼ 198.34K |
| Lpl Financial LLC | 151.57K | ▲ 33.51K |
| Citigroup Inc | 118.47K | ▼ 200.14K |
| Miller Investment Management, LP | 101.26K | ▲ 1.00K |
| Royal Bank Of Canada | 95.47K | ▼ 265.53K |
Held by 14 ETFs
Biggest fund positions in PPH by dollar value.
Our PPH coverage
Recent articles, reports, and earnings notes.
No research on PPH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PPH report →Which Healthcare ETF Is the Better Buy: VanEck's Pharma Fund PPH or iShares' Biotech Fund IBB?
fool.com · Nov 15
ETFs in Spotlight as FDA Vision Loss Warning Meets Lilly's Sleep Apnea Win
zacks.com · Nov 11
Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF
fool.com · Oct 30
PPH: Key Pharmaceutical Innovations Support Bullish Outlook (Upgrade)
seekingalpha.com · Oct 29
Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH?
fool.com · Oct 26
Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?
fool.com · Oct 11
Execution of Pharma Tariffs Brings These ETFs Into Focus
zacks.com · Oct 6
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
zacks.com · Oct 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.